Cargando…
The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study
JNJ-42165279 is a selective inhibitor of fatty acid amide hydrolase (FAAH), the enzyme responsible for the degradation of fatty acid amides (FAA) including anandamide (AEA), palmitoylethanolamide (PEA), and N-oleoylethanolamide (OEA). We assessed the efficacy, safety, tolerability, pharmacokinetics,...
Autores principales: | Schmidt, Mark E., Liebowitz, Michael R., Stein, Murray B., Grunfeld, Jennifer, Van Hove, Ilse, Simmons, W. Kyle, Van Der Ark, Peter, Palmer, James A., Saad, Ziad S., Pemberton, Darrel J., Van Nueten, Luc, Drevets, Wayne C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115178/ https://www.ncbi.nlm.nih.gov/pubmed/33070154 http://dx.doi.org/10.1038/s41386-020-00888-1 |
Ejemplares similares
-
Fatty Acid Amide Hydrolase Inhibition by JNJ‐42165279: A Multiple‐Ascending Dose and a Positron Emission Tomography Study in Healthy Volunteers
por: Postnov, Andrey, et al.
Publicado: (2018) -
The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder
por: Recourt, Kasper, et al.
Publicado: (2019) -
Correction to: The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder
por: Recourt, Kasper, et al.
Publicado: (2019) -
The Molecular Basis for Dual Fatty Acid Amide Hydrolase (FAAH)/Cyclooxygenase (COX) Inhibition
por: Palermo, Giulia, et al.
Publicado: (2015) -
Characterization of the central nervous system penetrant and selective purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder
por: Recourt, Kasper, et al.
Publicado: (2023)